| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 10.593 | 0 |
| Total Income - EUR | - | - | - | - | - | - | - | 0 | 10.593 | 0 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 62 | 10.094 | 11.088 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -62 | 500 | -11.088 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -62 | 394 | -11.088 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Andagrosib S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 404 | 402 |
| Current Assets | - | - | - | - | - | - | - | 41 | 12.779 | 4.988 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 532 |
| Receivables | - | - | - | - | - | - | - | 41 | 12.606 | 501 |
| Cash | - | - | - | - | - | - | - | 0 | 173 | 3.955 |
| Shareholders Funds | - | - | - | - | - | - | - | -22 | 372 | -10.718 |
| Social Capital | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Debts | - | - | - | - | - | - | - | 62 | 12.812 | 16.108 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "145 - 145" | |||||||||
| CAEN Financial Year |
145
|
|||||||||
Comments - Andagrosib S.r.l.